Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Hepatol. 2016 Apr 4;65(2):252–258. doi: 10.1016/j.jhep.2016.03.016

Fig. 3. YLVL inhibits primary NK cell function when presented on HLA-C*03:04 cells.

Fig. 3

(A) Representative staining of CD107a on NK cells after co-incubation with peptide pulsed 721.221-ICP47-C*03:04. Control without CD107a-AB (white), NK cells without target cells (light grey), KIR2DL3- (dark grey) and KIR2DL3+ (black) NK cells against YLVL pulsed target cells. The numbers represent the % of CD107a+ NK cells for the depicted measurement. (B) Relative frequency of CD107a+ NK cells when co-cultured with 721.221-ICP47-C*03:04 cells pulsed with YLVL compared to GKL control. Each bar represents mean +/− SEM of 7 independent experiments for each peptide.